for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-AstraZeneca Says COVID-19 Vaccine AZD1222 Clinical Trial Resumed In Japan

Oct 2 (Reuters) - AstraZeneca PLC:

* ASTRAZENECA - COVID-19 VACCINE AZD1222 CLINICAL TRIAL RESUMED IN JAPAN

* ASTRAZENECA - CONTINUES TO WORK FDA TO FACILITATE REVIEW OF INFORMATION NEEDED TO MAKE A DECISION REGARDING RESUMPTION OF US TRIAL Source text : bit.ly/2GieQBb Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up